GGrantIndex
← Leaderboards

Ravindra Majeti

Stanford University

$8,518,864
Attributed
$10,697,512
Total exposure
9
Grants
7
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $2.2M · FY201425
$2.5M$1.9M$1.3M$625K$0
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$10,697,512 · 9

By mechanism

R01$8,608,171 · 6
T32$1,270,180 · 1
R21$819,161 · 2

Top collaborators

Most similar at Stanford University

Same institution · by research overlap

Others in their field

Top investigators on “Cells

Research focus

CellsBone MarrowGenesComplexIn VivoPropertyGenomicsMalignant NeoplasmsMutationSelf-RenewalAcute Myelocytic LeukemiaAffectInvestigationHematopoietic Stem CellsProgramsTransplantationHematopoietic Cell TransplantationAllogenicHigh Dose ChemotherapyRelapseMyeloid CellsBiologicalAdultIn Vitro

Grant awards (27)

Clonal Hematopoiesis Aging Resiliency Mechanisms$1,304,118
R01 · FY2025 · AG
Pre-Leukemic Hematopoietic Stem Cells in Human AML$487,973
R01 · FY2025 · CA · contact PI
Functional Interrogation of Human Acute Myeloid Leukemia Stem Cells$439,644
R01 · FY2025 · CA · contact PI
Clonal Hematopoiesis Aging Resiliency Mechanisms$1,349,483
R01 · FY2024 · AG
Human Acute Myeloid Leukemia Stem Cells$348,569
R01 · FY2024 · CA · contact PI
Human Acute Myeloid Leukemia Stem Cells$359,399
R01 · FY2023 · CA · contact PI
Program in Translational and Experimental Hematology$205,471
T32 · FY2023 · HL · contact PI
Human Acute Myeloid Leukemia Stem Cells$359,228
R01 · FY2022 · CA · contact PI
Program in Translational and Experimental Hematology$333,145
T32 · FY2022 · HL · contact PI
Frequent concatemeric insertions during AAV6/Cas9-mediated genome editing: Detection and Prevention$197,415
R21 · FY2022 · OD
Epigenetic, Transcriptional, and Microenvironmental Determinants of Human HSC Self-Renewal$397,470
R01 · FY2021 · HL · contact PI
Human Acute Myeloid Leukemia Stem Cells$366,390
R01 · FY2021 · CA · contact PI
Frequent concatemeric insertions during AAV6/Cas9-mediated genome editing: Detection and Prevention$236,936
R21 · FY2021 · OD
Program in Translational and Experimental Hematology$199,232
T32 · FY2021 · HL · contact PI
Epigenetic, Transcriptional, and Microenvironmental Determinants of Human HSC Self-Renewal$397,326
R01 · FY2020 · HL · contact PI
Human Acute Myeloid Leukemia Stem Cells$366,225
R01 · FY2020 · CA · contact PI
Program in Translational and Experimental Hematology$219,331
T32 · FY2020 · HL · contact PI
Epigenetic, Transcriptional, and Microenvironmental Determinants of Human HSC Self-Renewal$397,186
R01 · FY2019 · HL · contact PI
Program in Translational and Experimental Hematology$313,001
T32 · FY2019 · HL · contact PI
Epigenetic, Transcriptional, and Microenvironmental Determinants of Human HSC Self-Renewal$397,048
R01 · FY2018 · HL · contact PI
Pre-Leukemic Hematopoietic Stem Cells and Clonal Evolution in Human AML$328,405
R01 · FY2018 · CA · contact PI
Pre-Leukemic Hematopoietic Stem Cells and Clonal Evolution in Human AML$328,076
R01 · FY2017 · CA · contact PI
Pre-Leukemic Hematopoietic Stem Cells and Clonal Evolution in Human AML$327,765
R01 · FY2016 · CA · contact PI
Discovery of Synthetic Lethals in Pan-Cancer Genomic Data Using Boolean Methods$210,266
R21 · FY2016 · CA · contact PI
Pre-Leukemic Hematopoietic Stem Cells and Clonal Evolution in Human AML$327,202
R01 · FY2015 · CA · contact PI
Discovery of Synthetic Lethals in Pan-Cancer Genomic Data Using Boolean Methods$174,544
R21 · FY2015 · CA · contact PI
Pre-Leukemic Hematopoietic Stem Cells and Clonal Evolution in Human AML$326,664
R01 · FY2014 · CA · contact PI